LAURENCE S. FARER, M.D., M.P.H.; JEFFREY L. GLASSROTH, M.D.; DIXIE E. SNIDER JR., M.D.
To the editor: The letter from Drs. Moulding, Iseman, and Sbarbaro (Ann Intern Med 85:398-399, 1976) contains some misinformation concerning Public Health Service data on isoniazid-related hepatotoxicity. Using criteria established by a panel of experts in hepatic disease, the Public Health Service study showed that the incidence of hepatotoxicity was 2.3% per year for persons 50 to 64 years of age and 0.8% for persons over 64 years of age (1). Therefore, the statement ". . . the incidence of hepatotoxicity . . . for persons above 50 years, 2.3% per year" is incorrect. The rate for all persons 50
Learn more about subscription options.
Register Now for a free account.
FARER LS, GLASSROTH JL, SNIDER DE. Isoniazid-Related Hepatotoxicity. Ann Intern Med. 1977;86:114–115. doi: 10.7326/0003-4819-86-1-114_2
Download citation file:
Published: Ann Intern Med. 1977;86(1):114-115.
Emergency Medicine, Gastroenterology/Hepatology, Liver Disease.
Results provided by:
Copyright © 2017 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only